Literature DB >> 16780325

Novel biscapped and monocapped tris(dioxime) Mn(II) complexes: x-ray crystal structure of the first cationic tris(dioxime) Mn(II) complex [Mn(CDOH)3BPh]OH (CDOH2= 1,2-cyclohexanedione dioxime).

Wen-Yuan Hsieh1, Shuang Liu.   

Abstract

This report describes the synthesis and characterization of a series of novel biscapped and monocapped tris(dioxime) Mn(II) complexes [Mn(dioxime)3(BR)2] and [Mn(dioxime)3BR]+ (dioxime = cyclohexanedione dioxime (CDOH2) and 1,2-dimethylglyoxyl dioxime (DMGH(2)); R = Me, n-Bu, and Ph). All tris(dioxime) Mn(II) complexes have been characterized by elemental analysis, IR, UV/vis, cyclic voltammetry, ESI-MS, and, in the cases of [Mn(CDOH)3BPh]OH.CHCl3 and [Mn(CDO)(CDOH)2(BBu(OC2H5))2], X-ray crystallography. It was found that biscapped Mn(II) complexes [Mn(dioxime)3(BR)2] are not stable in the presence of water and readily hydrolyze to form monocapped cationic complexes [M(dioxime)3BR]+. This instability is most likely caused by mismatch between the size of Mn(II) and the coordination cavity of the biscapped tris(dioxime) ligands. In contrast, monocapped cationic complexes [M(dioxime)3BR]+ are very stable in aqueous solution even in the presence of PDTA (1,2-diaminopropane-N,N,N',N'-tetraacetic acid) because of the kinetic inertness imposed by the monocapped tris(dioxime) chelators that are able to completely "wrap" Mn(II) into their N6 coordination cavity. [Mn(CDO)3BPh]OH has a distorted trigonal prismatic coordination geometry, with the Mn(II) being bonded by six imine-N donors. The hydroxyl groups from three dioxime chelating arms form very strong intramolecular hydrogen bonds with the hydroxide counterion so that the structure of [Mn(CDOH)3BPh]OH can be considered as being the clathrochelate with the hydroxide counterion as a "cap".

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780325      PMCID: PMC2593905          DOI: 10.1021/ic060216n

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  24 in total

1.  Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).

Authors:  M P Federle; J L Chezmar; D L Rubin; J C Weinreb; P C Freeny; R C Semelka; J J Brown; J A Borello; J K Lee; R Mattrey; A H Dachman; S Saini; B Harmon; M Fenstermacher; R E Pelsang; S E Harms; D G Mitchell; H H Halford; M W Anderson; C D Johnson; I R Francis; J G Bova; P J Kenney; D L Klippenstein; G S Foster; D A Turner
Journal:  J Magn Reson Imaging       Date:  2000-07       Impact factor: 4.813

2.  Functional mimics of superoxide dismutase enzymes as therapeutic agents.

Authors:  D P Riley
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

3.  Computer-aided design (CAD) of Mn(II) complexes: superoxide dismutase mimetics with catalytic activity exceeding the native enzyme.

Authors:  K Aston; N Rath; A Naik; U Slomczynska; O F Schall; D P Riley
Journal:  Inorg Chem       Date:  2001-04-09       Impact factor: 5.165

4.  Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.

Authors:  M Federle; J Chezmar; D L Rubin; J Weinreb; P Freeny; U P Schmiedl; J J Brown; J A Borrello; J K Lee; R C Semelka; R Mattrey; A H Dachman; S Saini; S E Harms; D G Mitchell; M W Anderson; H H Halford; W F Bennett; S W Young; M Rifkin; S B Gay; R Ballerini; P F Sherwin; R O Robison
Journal:  J Magn Reson Imaging       Date:  2000-11       Impact factor: 4.813

5.  Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.

Authors:  Silvio Aime; Lucio Anelli; Mauro Botta; Marino Brocchetta; Simonetta Canton; Franco Fedeli; Eliana Gianolio; Enzo Terreno
Journal:  J Biol Inorg Chem       Date:  2001-07-12       Impact factor: 3.358

6.  A neutral technetium-99m complex for myocardial imaging.

Authors:  R K Narra; A D Nunn; B L Kuczynski; T Feld; P Wedeking; W C Eckelman
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

7.  Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts.

Authors:  H Brurok; T Skoglund; K Berg; S Skarra; J O Karlsson; P Jynge
Journal:  NMR Biomed       Date:  1999-10       Impact factor: 4.044

8.  M40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heart.

Authors:  Clara Di Filippo; Salvatore Cuzzocrea; Raffaele Marfella; Valentina Fabbroni; Giuseppe Scollo; Liberato Berrino; Dario Giugliano; Francesco Rossi; Michele D'Amico
Journal:  Eur J Pharmacol       Date:  2004-08-16       Impact factor: 4.432

9.  Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent.

Authors:  Jeffrey S Troughton; Matthew T Greenfield; Jaclyn M Greenwood; Stéphane Dumas; Andrea J Wiethoff; Jufeng Wang; Marga Spiller; Thomas J McMurry; Peter Caravan
Journal:  Inorg Chem       Date:  2004-10-04       Impact factor: 5.165

10.  Regional distribution of manganese found in the brain after injection of a single dose of manganese-based contrast agents.

Authors:  B Gallez; C Baudelet; M Geurts
Journal:  Magn Reson Imaging       Date:  1998-12       Impact factor: 2.546

View more
  1 in total

1.  Ligand design of zero-field splitting in trigonal prismatic Ni(II) cage complexes.

Authors:  Anthony J Campanella; Tyler M Ozvat; Joseph M Zadrozny
Journal:  Dalton Trans       Date:  2022-02-22       Impact factor: 4.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.